Average Co-Inventor Count = 4.57
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Biogen Idec Ma Inc. (3 from 216 patents)
2. University Of Zürich (3 from 97 patents)
3. Biogen International Neuroscience Gmbh (3 from 12 patents)
4. Biogen Ma Inc. (2 from 250 patents)
5. Ucb Biopharma Sprl (2 from 138 patents)
6. Ucb Pharma, S.a. (1 from 179 patents)
8 patents:
1. 10301381 - Anti-alpha synuclein binding molecules
2. 9975947 - Anti-alpha synuclein binding molecules
3. 9580493 - Anti-α synuclein binding molecules
4. 9321840 - Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereof
5. 9297810 - CD40L-binding agent based platelet aggregation assays
6. 8784823 - Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereof
7. 8409810 - Platelet aggregation assays using a CD40L-binding agent
8. 8293237 - Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereof